UPC

Healthcare Drug Manufacturers - Specialty & Generic

Universe Pharmaceuticals INC

$4.50

+0.43 +10.56% today

Price History

Not enough data

Key Stats

Market Cap

22.61M

Avg Volume

802,564

EPS

-$1.38

52W High

$17.96

52W Low

$2.00

Div. Yield

0.0%

Valuation

P/B Ratio

0.05

P/S Ratio

1.27

EV/EBITDA

10.53

EV/Revenue

-0.96

Margins

Gross Margin 36.5%

Operating Margin (16.6%)

Net Margin (10.9%)

EBITDA Margin (9.1%)

Growth & Returns

Revenue Growth (YoY)

(1.3%)

Return on Equity

(3.5%)

Return on Assets

(1.7%)

Liquidity & Leverage

Current Ratio

4.05

Quick Ratio

3.25

Debt / Equity

0.17

Total Cash

29.05M

Total Debt

9.55M

About

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu pill; yangxue danggui and qiangli pipa syrup; wuzi yanzong oral, fengtong medicinal, shenrong medicinal, qishe medicinal, fengshitong medicinal, and shiquan dabu medicinal liquor; paracetamol granule for children; and isatis root granule. In addition, the company distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. It primarily serves pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is headquartered in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.